Intec Pharma

NTEC NASDAQ
0.4602
+0.0130
+2.91%
After Hours: 0.4602 0 0.00% 16:00 08/23 EDT
Open
0.4545
Prev Close
0.4472
High
0.4797
Low
0.4351
Volume
540.01K
Avg Vol (3M)
1.22M
52 Week High
9.25
52 Week Low
0.4100
% Turnover
2.07%
Market Cap
12.00M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Intec Pharma NTEC stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodynamics of various drugs. The Company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill-Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Furthermore under research is Accordion Pill-Undisclosed Drug for the prevention and treatment of small bowel non-steroidal anti-inflammatory drug (NSAID) induced ulcers.
MORE >

Recently

Name
Price
%Change